PHYSICIAN-PATIENT RESEARCH PLATFORM
Advancing the science of exosomes.
Regenova connects patients with physicians and gives clinicians a standardized way to document care. That structured record becomes the evidence base physicians draw on to advance their own clinical research into stem-cell-derived exosomes and their cargo.
Regenova is a documentation and research platform, not a medical provider. Exosome therapies are investigational, not FDA-approved, and every clinical decision is made by your physician.
01 · THE CHOICE
A surgeon’s first recommendation isn’t always your only option.
After a serious accident or years of chronic pain, spinal surgery is often the first thing offered. For the right patient, regenerative injection therapies studied in clinical research may offer relief without the risks, recovery, and irreversibility of the operating room. Regenova helps you find a board-certified physician and make an informed choice.
The Regenova path
REGENERATIVE INJECTION THERAPY
- In-office, ~15-minute procedure
- Local anesthetic, minimal downtime
- Non-surgical and tissue-sparing
- Studied in clinical research
AFTER SURGERY · PERMANENT HARDWAREThe traditional path
INVASIVE SPINAL SURGERY
- Laminectomy, discectomy, or fusion
- Weeks to months of recovery and rehab
- Surgical and anesthesia risk
- Permanent, structural, hard to reverse
PHYSICIAN-DIRECTED CARE
“Surgery is the right answer for some patients, and we’ll always say so. Regenova exists so the decision is made with the full picture — and by a physician who does this every day.”
Board-certified physician · Dr. Kevin Pauza, MD
02 · TWO SIDES, ONE RECORD
Written in the room, and every week after.
Regenova gives the physician an ambient scribe that turns a visit into structured, de-identified data, and gives the patient an app that keeps the conversation going between appointments. Better data for the research, and a patient who stays connected to specialist-level care, wherever they are.
Ambient scribe · a structured, de-identified note in seconds
Every visit, structured
An ambient scribe captures each encounter the same de-identified way, so the clinical picture is never lost to hurried free-text.
Every week, a check-in
Between appointments, patients report how they're doing. Gentle outreach and short questionnaires keep the signal, and the relationship, alive.
One record over time
Visit notes and check-ins compound into a single longitudinal timeline the physician follows, and that de-identified research can build on.
03 · THE SCIENCE
It isn’t a new cell. It’s the message the body already uses.
Exosomes are the tiny vesicles cells use to signal one another, carrying the proteins and genetic messengers that prompt repair and calm inflammation. Regenova sources, standardizes, and characterizes that signal, then puts the evidence in plain view.
- VESICLE SIZE
- 30–150 nm
- CARGO
- mRNA · miRNA · proteins
- FUNCTION
- Cell-to-cell signaling
04 · FROM PAIN TO A PLAN
How Regenova works.
- 01
Learn
Understand your diagnosis and what regenerative therapies actually are, in plain language, before any appointment.
- 02
Match
We connect you with a board-certified physician in our network who focuses on regenerative and interventional pain care.
- 03
Evaluate
The physician reviews your imaging and history and gives you an honest assessment, including whether surgery is the better call.
- 04
Treat
If you’re a candidate, a physician-directed regenerative injection is performed in an outpatient setting.
- 05
Track
Your recovery and outcomes are tracked over time with AI-assisted follow-up, so progress is measured, not guessed.
05 · FOR PHYSICIANS & CLINICS
The infrastructure behind better pain care.
Regenova is technology, education, and outcomes infrastructure for independent, board-certified physicians. You practice medicine and own your patient relationships. We handle the documentation, the standards, and the data that make regenerative care credible and repeatable.
AI clinical documentation
Structured, compliant notes drafted from each visit, so charting takes minutes and reads the same across every provider.
Standardized protocols
Consistent intake, consent, and treatment workflows built around the evidence, not around any one clinic’s habits.
Outcomes registry
Every patient’s recovery is followed over time, giving you a real record of what worked, for whom, and how well.
Patient education pipeline
We reach and inform patients through education and awareness, so the people who arrive already understand the therapy.
Regenova does not pay for referrals and is not a fee-for-referral network. Physicians make independent clinical decisions; patients are never a commodity.
06 · THE DATA PLATFORM
Relief you can measure. Evidence that compounds.
Regenerative medicine advances when outcomes are tracked, not anecdotal. Every Regenova visit is documented in a structured, AI-assisted way and followed over time. As de-identified outcomes accumulate, they lay the groundwork for future clinical studies, and for the pharmacogenomic and FDA-forward pathways that move alternatives to surgery ahead for everyone.
One standard of documentation
Every Regenova visit is captured the same structured way. Consistency is what turns scattered charts into a dataset worth studying.
De-identified by design
Outcomes are aggregated and de-identified. Patient privacy comes first; the research value comes from the pattern, not the person.
A foundation for research
Over time this becomes one of the most complete records in regenerative pain care, groundwork for future clinical studies and next-generation therapies.
07 · OUR MISSION
“Surgery should be a decision, not a default. We connect people in pain to physicians offering clinically studied, less-invasive care, and we standardize every step so the outcomes become evidence the whole field can stand on.”
Regenova, a Cre8ive Labs venture
FAQ
Questions, answered.
For some patients, it can be. Regenerative injection therapies studied in clinical research may offer relief without the risks and recovery of surgery. Whether they're right for you depends on your diagnosis and a board-certified physician's assessment. Regenova helps you get that evaluation.
Exosomes are cell-signaling particles being studied in regenerative medicine. They are not FDA-approved treatments; the therapies referenced here are investigational and physician-directed. Any treatment decision is made with a licensed physician.
Injury-related and chronic pain, including back and neck pain, neuropathic pain, and pain following spinal injury or trauma: the situations where surgery is often the first thing offered.
Reach out and we'll connect you with a board-certified physician in our network for an evaluation. Regenova is a technology and education platform; it does not provide medical care itself, and it's not a substitute for your physician's advice.
Before the operating room, get a second opinion.
Whether you’re a patient exploring alternatives or a physician who wants to offer them, we’d like to hear from you.
Regenova is a technology and education platform. It is not medical advice and does not provide medical care. Regenerative therapies referenced here are studied in clinical research and are not FDA-approved treatments; they are not a substitute for care recommended by your physician. Individual results vary. Always consult a licensed physician about your diagnosis and options.